This inventor holds 3 USPTO granted patents and 8 published patent applications and 1 EPO patent. Top assignees: Berkeley Lights, Inc., University of California. Active years: 2019-2023.
Company Filing History:
3 out of 75 
1 out of 15,988 
Years Active: 2019-2023
Title: Magali Soumillon: Innovator in Genome Editing Technologies
Introduction
Magali Soumillon is a prominent inventor based in Berkeley, CA, known for her significant contributions to the field of genome editing. With a total of 3 patents to her name, she has been at the forefront of developing innovative methods for the selection and generation of genome-edited T cells.
Latest Patents
Her latest patents include groundbreaking methods for isolating clonal populations of T cells with defined genetic modifications. One of her notable inventions describes methods performed in a microfluidic device that includes sequestration pens. These methods involve maintaining individual T cells that have undergone genomic editing, expanding them into clonal populations, and detecting specific nucleic acid sequences indicative of successful genome edits. Another patent focuses on similar methods for isolating clonal populations of cells, emphasizing the use of microfluidic devices for efficient genome editing.
Career Highlights
Magali has worked with notable organizations such as Berkeley Lights, Inc. and the University of California. Her work has significantly advanced the understanding and application of genome editing technologies, making her a key figure in this innovative field.
Collaborations
Throughout her career, Magali has collaborated with esteemed colleagues, including Annamaria Mocciaro and Gregory G Lavieu. These partnerships have further enriched her research and contributions to the scientific community.
Conclusion
Magali Soumillon's innovative work in genome editing technologies has positioned her as a leading inventor in her field. Her patents reflect her commitment to advancing scientific knowledge and improving therapeutic techniques.